{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:37:35Z","timestamp":1768279055006,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,15]]},"DOI":"10.7759\/cureus.23200","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:48:00Z","timestamp":1647409680000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Efficacy of Combined Intralesional Sodium Stibogluconate Plus Topical Imiquimod on Healing and Risk of Scarring of Cutaneous Leishmaniasis: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Samer A","family":"Dhaher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaar A","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Protozoa and Worms","author":"Nelson SA","year":"2012","unstructured":"Nelson SA, Warschaw KE. Protozoa and Worms. Dermatology 3rd edition. Bolognia JL, Jorrizo JL, Schaffer JV (ed): Elsevier, New York; 2012. 1391-413."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.11.008","article-title":"Cutaneous leishmaniasis in Texas: a northern spread of endemic areas","volume":"58","author":"Wright NA","year":"2008","unstructured":"Wright NA, Davis LE, Aftergut KS, Parrish CA, Cockerell CJ. Cutaneous leishmaniasis in Texas: a northern spread of endemic areas. J Am Acad Dermatol. 2008, 58:650-2. 10.1016\/j.jaad.2007.11.008","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger R","year":"2007","unstructured":"Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007, 7:581-96. 10.1016\/S1473-3099(07)70209-8","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-008-1111-4","article-title":"Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods","volume":"103","author":"Shahbazi F","year":"2008","unstructured":"Shahbazi F, Shahabi S, Kazemi B, Mohebali M, Abadi AR, Zare Z. Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods. Parasitol Res. 2008, 103:1159-62. 10.1007\/s00436-008-1111-4","journal-title":"Parasitol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3201\/eid1506.090101","article-title":"Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe","volume":"15","author":"Xynos ID","year":"2009","unstructured":"Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV. Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe. Emerg Infect Dis. 2009, 15:956-9. 10.3201\/eid1506.090101","journal-title":"Emerg Infect Dis"},{"key":"ref6","article-title":"Immunomodulators","author":"Jackson JM","year":"2012","unstructured":"Jackson JM, Callen JP. Immunomodulators. Dermatology 3rd ed. Bolognia JL, Jorrizo JL, Schaffer JV (ed): Elsevier, New York; 2012. 2131-47."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi H","year":"2002","unstructured":"Hemmi H, Kaisho T, Takeuchi O, et al.. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002, 3:196-200. 10.1038\/ni758","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg ML","year":"2003","unstructured":"Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003, 3:984-93. 10.1038\/nri1246","journal-title":"Nat Rev Immunol"},{"key":"ref9","article-title":"Update in the treatment of cutaneous leishmaniasis","volume":"16","author":"Al-Natour SH","year":"2009","unstructured":"Al-Natour SH. Update in the treatment of cutaneous leishmaniasis. J Family Community Med. 2009, 16:41-7.","journal-title":"J Family Community Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey F","year":"2017","unstructured":"Bailey F, Mondragon-Shem K, Hotez P, Ruiz-Postigo JA, Al-Salem W, Acosta-Serrano \u00c1, Molyneux DH. A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis. 2017, 11:e0005739. 10.1371\/journal.pntd.0005739","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181822e90","article-title":"Current treatment for cutaneous leishmaniasis: a review","volume":"16","author":"Palumbo E","year":"2009","unstructured":"Palumbo E. Current treatment for cutaneous leishmaniasis: a review. Am J Ther. 2009, 16:178-82. 10.1097\/MJT.0b013e3181822e90","journal-title":"Am J Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the middle East: incidence and epidemiology","volume":"8","author":"Salam N","year":"2014","unstructured":"Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the middle East: incidence and epidemiology. PLoS Negl Trop Dis. 2014, 8:e3208. 10.1371\/journal.pntd.0003208","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107806","article-title":"Imiquimod in clinical practice","volume":"43","author":"Edwards L","year":"2000","unstructured":"Edwards L. Imiquimod in clinical practice. J Am Acad Dermatol. 2000, 43:S12-7. 10.1067\/mjd.2000.107806","journal-title":"J Am Acad Dermatol"},{"key":"ref14","article-title":"Medical pharmacology and therapeutics. 2nd edition","author":"Waller DG","year":"2005","unstructured":"Waller DG, Renwick AG, Hillier K. Medical pharmacology and therapeutics. 2nd edition. Saunders (W.B.) Co Ltd, Oxford; 2005."},{"key":"ref15","article-title":"Reinfestation in cutaneous leishmaniasis: a new look at predisposing conditions","volume":"21","author":"Sharquie KE","year":"2000","unstructured":"Sharquie KE, Najim RA, Hussein AK. Reinfestation in cutaneous leishmaniasis: a new look at predisposing conditions. Saudi Med J. 2000, 21:464-7.","journal-title":"Saudi Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03157.x","article-title":"Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate","volume":"23","author":"Solomon M","year":"2009","unstructured":"Solomon M, Baum S, Barzilai A, Pavlotsky F, Trau H, Schwartz E. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. J Eur Acad Dermatol Venereol. 2009, 23:1189-92. 10.1111\/j.1468-3083.2009.03157.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","article-title":"A comparison between intralesional hypertonic sodium chloride solution and meglumine antimoniate in the treatment of cutaneous leishmaniasis","volume":"8","author":"Sadeghian G","year":"2005","unstructured":"Sadeghian G, Nilfroushzadeh MA., Siadat AH. A comparison between intralesional hypertonic sodium chloride solution and meglumine antimoniate in the treatment of cutaneous leishmaniasis. Iran J Dermatol. 2005, 8:251-5.","journal-title":"Iran J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Ver\u00e1stegui C","year":"2005","unstructured":"Miranda-Ver\u00e1stegui C, Llanos-Cuentas A, Ar\u00e9valo I, Ward BJ, Matlashewski G. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis. 2005, 40:1395-403. 10.1086\/429238","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang WW","year":"2008","unstructured":"Zhang WW, Matlashewski G. Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice. Infect Immun. 2008, 76:3777-83. 10.1128\/IAI.01527-07","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126585","article-title":"Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids","volume":"47","author":"Berman B","year":"2002","unstructured":"Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol. 2002, 47:S209-11. 10.1067\/mjd.2002.126585","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01955.x","article-title":"Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod","volume":"42","author":"Seeberger J","year":"2003","unstructured":"Seeberger J, Daoud S, Pammer J. Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod. Int J Dermatol. 2003, 42:576-9. 10.1046\/j.1365-4362.2003.01955.x","journal-title":"Int J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz A","year":"2006","unstructured":"Firooz A, Khamesipour A, Ghoorchi MH, et al.. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Arch Dermatol. 2006, 142:1575-9. 10.1001\/archderm.142.12.1575","journal-title":"Arch Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo I","year":"2001","unstructured":"Arevalo I, Ward B, Miller R, et al.. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis. 2001, 33:1847-51. 10.1086\/324161","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.481","article-title":"Comparative study of the efficacy of combined imiquimod 5% cream and intralesional meglumine antimoniate versus imiquimod 5% cream and intralesional meglumine antimoniate alone for the treatment of cutaneous leishmaniasis","volume":"52","author":"Crawford R","year":"2005","unstructured":"Crawford R, Holmes D, Meymandi S. Comparative study of the efficacy of combined imiquimod 5% cream and intralesional meglumine antimoniate versus imiquimod 5% cream and intralesional meglumine antimoniate alone for the treatment of cutaneous leishmaniasis. J Am Acad Dermatol. 2005, 52:1575-9. 10.1016\/j.jaad.2004.10.481","journal-title":"J Am Acad Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft SL","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006, 19:111-26. 10.1128\/CMR.19.1.111-126.2006","journal-title":"Clin Microbiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87383-evaluating-the-efficacy-of-combined-intralesional-sodium-stibogluconate-plus-topical-imiquimod-on-healing-and-risk-of-scarring-of-cutaneous-leishmaniasis-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:27Z","timestamp":1707507327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87383-evaluating-the-efficacy-of-combined-intralesional-sodium-stibogluconate-plus-topical-imiquimod-on-healing-and-risk-of-scarring-of-cutaneous-leishmaniasis-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.23200","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,15]]}}}